Upload
skyler-lane
View
95
Download
0
Embed Size (px)
DESCRIPTION
药理学总论-绪言 Pharmacology A Very Basic Intro. What is a drug? any chemical agent which affects any biological process. Sources of Drugs. Animals Plants Minerals Synthetic Microbes Genetic engineering drugs. ③. ②限制酶截取 DNA 片断. ①. ④. ③分离大肠杆菌中的质粒. ②. ④ DNA 重组. ⑤. ⑤用重组质粒转化大肠杆菌. - PowerPoint PPT Presentation
Citation preview
药理学总论 -绪言PharmacologyPharmacology
A Very Basic Intro
What is a drug?
- any chemical agent which affects any biological process
Sources of Drugs
AnimalsPlants
MineralsSyntheticMicrobes
Genetic engineering drugs
基因工程药物过程示意图①① 从细胞中分从细胞中分
离出离出 DNADNA
①①
②②
③③
④④
⑤⑤
⑥⑥
②② 限制酶截取限制酶截取DNADNA 片断片断
③③ 分离大肠杆分离大肠杆菌中的质粒菌中的质粒
④ ④ DNADNA 重组重组
⑤⑤ 用重组质粒用重组质粒转化大肠杆菌转化大肠杆菌
⑥⑥ 培养大肠杆菌培养大肠杆菌克隆大量基因克隆大量基因
A goal of Genomics is to find and express genes that code for unknown peptides with significant biological properties, like receptors or enzymes. In a reverse Pharmacology approach this peptide, e.g. a receptor, is then used to "fish" for a natural ligand . With receptor and ligand in hand the biological role of the receptor needs to be determined. Finally, screening for synthetic ligands as well as lead optimization can lead to new drug candidates. In contrast, the classical approach to drug discovery starts with the identification of a ligand that has biological activity that in turn is used to "fish" for the corresponding receptor.
One example for a Genomics strategy aims at identifying drug targets based on molecular homology within Gene-families. One of the most important families of drug-targets for the pharmaceutical industry is the family of G-protein coupled receptors (GPCRs). Of the top 200 best selling prescription drugs, more than 20% interact with GPCRs, providing worldwide sales of over $20 billion. The characteristic motif of the GPCR family is the seven distinct hydrophobic regions, each of 20 to 30 amino acids that form the transmembrane domain of these integral membrane proteins. This key amino-acid sequence motif can be found within all types of GPCRs and can be used to identify DNA-sequences that code for GPCRs.
What is pharmacology ?
- the study of how drugs effect biological systems
What is Pharmacology ?
Pharmacology
Pharmacokinetics Pharmacodynamics
What the body does to drug What the drug does to body
Pharmacotherapeutics Pharmacocognosy
The study of the use of drugs Identifying crude materials as drugs
Toxicology
PharmacokineticsWhat the body does to the drug
- Absorption- Distribution- Metabolism (Biotransformation)- Excretion
Half-life (t1/2)- the time required for the plasmaconcentration of a drug to be reduced by 50 %
DRUG CLASSIFICATION
- Based on the chemical structure
- Based on the main effect (e.g. analgesics).
- Based on the therapeutic use (e.g. antipsychotic 安定药).
-Based on mechanism of action (e.g. serotonin agonist).
From Chemist to
First In Man …approximately 7 – 10 years
How a Drug becomes a drug…
H. Haarmann University of Maryland, 2002
Basic & Clinical Evaluation of New Drugs
1. Drug discovery & Drug screeningChemistry
In Vitro StudiesFunction in cells, tissues, and at receptors
2. Preclinical safety & toxicity testingIn Vivo - Animal studies
Pharmacology and Behavioral PharmacologyPotency and Efficacy – ED50Tolerance and Tachyphylaxis( 快速耐受 )
Toxicity – Acute and Chronic LD50Teratogenicity = birth defectsCarcinogenicity = cancerous
3. Evaluation of drug in humans
Evaluating Drugs in Humans
The Food and Drug Administration (FDA)
Phases of a Clinical TrialsPhase I Phase II Phase III Phase IV
Evaluating Drugs in HumansPhase I – Healthy adult volunteers
• Evaluation of safety, Pharmacokinetics (PK), side effects???
Phase II - Patients• Evaluation of efficacy, safety, PK, and side effects• Double-blind placebo controlled
Phase III – Specific patient subpopulations• Determine efficacy for specific indications• Large sample of specific patients (1,000)• Randomized double-blind placebo controlled
Phase IV – Post FDA Approval• Determine efficacy for specific indication• Determine drug utilization patterns and additional efficacy• Monitor rare, severe side effects/toxicity
Drug Nomenclature
-Chemical name (化学名)- *Generic name (非专利名)
- Trade name (商品名) Chemical Name: 2-(4-isobutylphenyl)-propionic acid
Generic Name: ibuprofen(布洛芬)
Trade Names: Advil, Aches-N-Pain, Brufen, Emodin, Haltran, Medipren, Midol 200, Motrin, Nuprin, Rufen, Trendar, Wal-Profen
*preclinical nomenclature = company abbrev-123456 (e.g. WAY-100635, MK-869)